Applied Materials tumbles after issuing a disappointing fiscal first-quarter outlook, Palantir is transferring its stock ...
Shares of Pfizer (PFE) may be about to reverse and head higher. They are both oversold and at a support level.
Wolfe Research initiated coverage of Pfizer (PFE) with an Underperform rating and $25 price target While it can be challenging to move the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback